"Arthritis during interferon beta-1b treatment in multiple
sclerosis"
Altintas A, Alici Y, Melikoglu M, Siva A.
Department of Neurology, Cerrahpasa School of Medicine, 34300
Istanbul, Turkey.
aaltintas.md@superonline.com
Interferon beta (IFN-beta) is the most widely prescribed
disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta
may be associated with a number of adverse reactions.
The
development or exacerbation of other autoimmune diseases is a rare
but reported side effect of IFN-beta therapy.
In
this case report, we present clinical and laboratory findings of two
MS patients who developed arthritis during IFN-beta1b treatment,
probably of autoimmune origin.
Mult Scler. 2002 Dec;8(6):534-6.
PMID: 12474998 [PubMed
link] |
